Exosens (EPA:EXENS)
France flag France · Delayed Price · Currency is EUR
34.90
+1.07 (3.16%)
Apr 1, 2025, 11:44 AM CET

Exosens Statistics

Total Valuation

Exosens has a market cap or net worth of EUR 1.72 billion. The enterprise value is 1.83 billion.

Market Cap 1.72B
Enterprise Value 1.83B

Important Dates

The last earnings date was Monday, March 3, 2025.

Earnings Date Mar 3, 2025
Ex-Dividend Date n/a

Share Statistics

Exosens has 50.78 million shares outstanding.

Current Share Class n/a
Shares Outstanding 50.78M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) 25.72%
Float 27.50M

Valuation Ratios

The trailing PE ratio is 55.96 and the forward PE ratio is 22.83.

PE Ratio 55.96
Forward PE 22.83
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 94.39
P/FCF Ratio 31.29
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.63, with an EV/FCF ratio of 33.32.

EV / Earnings 59.58
EV / Sales 4.64
EV / EBITDA 16.63
EV / EBIT 25.02
EV / FCF 33.32

Financial Position

The company has a current ratio of 2.94, with a Debt / Equity ratio of 0.63.

Current Ratio 2.94
Quick Ratio 2.07
Debt / Equity 0.63
Debt / EBITDA 2.38
Debt / FCF 4.76
Interest Coverage 2.34

Financial Efficiency

Return on equity (ROE) is 9.96% and return on invested capital (ROIC) is 7.64%.

Return on Equity (ROE) 9.96%
Return on Assets (ROA) 6.20%
Return on Invested Capital (ROIC) 7.64%
Return on Capital Employed (ROCE) 10.30%
Revenue Per Employee 231,824
Profits Per Employee 18,059
Employee Count 1,700
Asset Turnover 0.53
Inventory Turnover 1.96

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 27.13
200-Day Moving Average 21.84
Relative Strength Index (RSI) 63.15
Average Volume (20 Days) 182,655

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Exosens had revenue of EUR 394.10 million and earned 30.70 million in profits.

Revenue 394.10M
Gross Profit 225.60M
Operating Income 73.10M
Pretax Income 41.80M
Net Income 30.70M
EBITDA 110.00M
EBIT 73.10M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has 150.20 million in cash and 261.30 million in debt, giving a net cash position of -111.10 million or -2.19 per share.

Cash & Cash Equivalents 150.20M
Total Debt 261.30M
Net Cash -111.10M
Net Cash Per Share -2.19
Equity (Book Value) 412.60M
Book Value Per Share n/a
Working Capital 207.20M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 96.20 million and capital expenditures -41.30 million, giving a free cash flow of 54.90 million.

Operating Cash Flow 96.20M
Capital Expenditures -41.30M
Free Cash Flow 54.90M
FCF Per Share 1.08
Full Cash Flow Statement

Margins

Gross margin is 57.24%, with operating and profit margins of 18.55% and 7.79%.

Gross Margin 57.24%
Operating Margin 18.55%
Pretax Margin 10.61%
Profit Margin 7.79%
EBITDA Margin 27.91%
EBIT Margin 18.55%
FCF Margin 13.93%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.30%.

Dividend Per Share 0.10
Dividend Yield 0.30%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield 0.30%
Earnings Yield 1.79%
FCF Yield 3.20%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a